WHAT’S HAPPENING

News and Events

Transition Bio is a dynamic, fast-growing company. Come back for regular updates.

News and Events ⟶      Posters and Presentations ⟶

News and Events

Transition Bio is pleased to attend this year’s #AACR24! Check out the exciting progress we’ve made on our frontrunner oncology programs and our #AI based.…

Learn More

Transition Bio, Inc., a microfluidics- driven drug discovery platform company using biophysical…

Learn More

Transition Bio, Inc. (the Company) today named several critical additions to its leadership team, including naming Gregory Miller as CEO…

Learn More

Transition Bio, Inc., (the Company) announced today that Dr. Sarah Teichmann FmedSci FRS, has joined.…

Learn More

New research from the departments of chemistry and physics at Cambridge University has just helped demonstrate the potential of natural…

Learn More

Transition Bio, Inc., announced today that Professor Peter St George-Hyslop, a world recognized pioneer…

Learn More

Transition Bio, Inc., was recently formed, funded, and launched with the focused objective to build the best…

Learn More

Posters and Presentations

Poster presented at #ENASymp24 (#Targets24)

See PDF

Posters presented at #AACR24

See PDF
See PDF
See PDF